Cargando…
Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness
Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure(®), Waltham, MA) for the supportive management of pure red cell aplasia i...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044386/ https://www.ncbi.nlm.nih.gov/pubmed/32128175 http://dx.doi.org/10.1002/ccr3.2626 |
_version_ | 1783501560030953472 |
---|---|
author | Rubinstein, Maria M. Goss, Cheryl Avecilla, Scott T. Dubé, Gregory P. Riely, Gregory J. Mones, Jodi V. |
author_facet | Rubinstein, Maria M. Goss, Cheryl Avecilla, Scott T. Dubé, Gregory P. Riely, Gregory J. Mones, Jodi V. |
author_sort | Rubinstein, Maria M. |
collection | PubMed |
description | Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure(®), Waltham, MA) for the supportive management of pure red cell aplasia in a Jehovah Witness patient. |
format | Online Article Text |
id | pubmed-7044386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70443862020-03-03 Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness Rubinstein, Maria M. Goss, Cheryl Avecilla, Scott T. Dubé, Gregory P. Riely, Gregory J. Mones, Jodi V. Clin Case Rep Case Reports Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure(®), Waltham, MA) for the supportive management of pure red cell aplasia in a Jehovah Witness patient. John Wiley and Sons Inc. 2019-12-26 /pmc/articles/PMC7044386/ /pubmed/32128175 http://dx.doi.org/10.1002/ccr3.2626 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Rubinstein, Maria M. Goss, Cheryl Avecilla, Scott T. Dubé, Gregory P. Riely, Gregory J. Mones, Jodi V. Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness |
title | Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness |
title_full | Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness |
title_fullStr | Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness |
title_full_unstemmed | Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness |
title_short | Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness |
title_sort | management of thymoma‐associated pure red cell aplasia: a novel use of blood substitute hboc‐201 in a jehovah’s witness |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044386/ https://www.ncbi.nlm.nih.gov/pubmed/32128175 http://dx.doi.org/10.1002/ccr3.2626 |
work_keys_str_mv | AT rubinsteinmariam managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness AT gosscheryl managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness AT avecillascottt managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness AT dubegregoryp managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness AT rielygregoryj managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness AT monesjodiv managementofthymomaassociatedpureredcellaplasiaanoveluseofbloodsubstitutehboc201inajehovahswitness |